Michael Heneka News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Leading scientific and clinical experts to provide perspectives and rationale for TREM2 and progranulin targets on December 7 and December 13, respectivelySOUTH SAN FRANCISCO, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced management will host two virtual events in December to discuss the Company’s TREM2 and progranulin (PGRN) programs. The events will include presentations from Alector’s managem

Public Release: 31-Aug-2018 Researchers at the University of Bonn determine how dangerous inflammations in the brain are caused University of Bonn IMAGE: Dr. Andras Bilkei-Gorzo and his colleagues have determined how endocannabinoids attenuate inflammatory reactions in the brain. Credit: © Photo: Kerstin Nicolai/Uni Bonn The so-called CB1 receptor is responsible for the intoxicating effect of…

04.08.2023 - AC Immune Reports Second Quarter 2023 Financial Results and Provides a Corporate Update Received FDA Fast Track Designation for ACI-24.060 anti-amyloid-beta (Abeta) active immunotherapy to treat Alzheimer’s disease (AD)Enrollment in ongoing Phase ...

Long before the onset of dementia, there is evidence for increased activity of the brain's immune system. Researchers from DZNE and the University Hospital Bonn come to this conclusion based on a study of more than 1,000 older adults.

Can an athlete’s blood enhance brainpower?